Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    ROF

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 75,357Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arcutis Unveils 2025 Financial Results And Business Update
    Arcutis Unveils 2025 Financial Results And Business Update

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244953/0/en/Arcutis-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Arcutis Reports Positive Phase 2 Results For ZORYVE Cream
    Arcutis Reports Positive Phase 2 Results For ZORYVE Cream

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230196/0/en/Arcutis-Announces-Positive-Topline-Results-for-INTEGUMENT-INFANT-Phase-2-Trial-of-ZORYVE-roflumilast-Cream-0-05-in-Infants-with-Mild-to-Moderate-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    Arcutis Bio Terminates Promotion Deal With Kowa
    Arcutis Bio Terminates Promotion Deal With Kowa

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225575/0/en/Arcutis-Biotherapeutics-Inc-Announces-Termination-of-Promotion-Agreement-with-Kowa.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Arcutis Outlines 2026 Strategic Goals And Milestones
    Arcutis Outlines 2026 Strategic Goals And Milestones

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216835/0/en/Arcutis-Highlights-2026-Strategic-Priorities-and-Anticipated-Milestones.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    FDA Accepts sNDA Arcutis' ZORYVE Cream For Pediatric Psoriasis
    FDA Accepts sNDA Arcutis' ZORYVE Cream For Pediatric Psoriasis

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189050/0/en/FDA-Accepts-Supplemental-New-Drug-Application-for-Arcutis-ZORYVE-roflumilast-Cream-0-3-for-the-Treatment-of-Plaque-Psoriasis-in-Children-Ages-2-to-5.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    Arcutis Wraps up Integument-Infant Ph 2 Study of Zoryve Cream
    Arcutis Wraps up Integument-Infant Ph 2 Study of Zoryve Cream

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187274/0/en/Arcutis-Completes-Enrollment-in-INTEGUMENT-INFANT-Phase-2-Study-Evaluating-ZORYVE-roflumilast-Cream-0-05-in-Infants-with-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.